Arthritis UK (formerly Versus Arthritis) logo
Arthritis UK (formerly Versus Arthritis)

Osteoarthritis Treatments Research Consortium

Funds a UK osteoarthritis drug-development consortium, up to £3 million over 5 years.

ClosedArthritis UK (formerly Versus Arthritis)United Kingdom

The Osteoarthritis Treatments Research Consortium is a grant from Arthritis UK (formerly Versus Arthritis) funding a single UK consortium to develop disease- and symptom-modifying osteoarthritis treatments, from small molecules and biologics to gene and cell therapies, regenerative medicine and repurposed existing drugs. This is a single-stage application process, but it opens with a mandatory Not…

This second osteoarthritis consortium call backs disease- and symptom-modifying pharmacotherapeutic treatments, spanning small molecules, biologics, gene and cell therapies, and regenerative medicine, plus repurposing existing drugs with known safety profiles. It wants a distributed portfolio of multiple treatments at different development stages, building a strong UK translational research community able to move quickly.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.1–60 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
European Commission logo
Scheduled

Cancer Mission: Functional Genomics for New Treatments

🇪🇺European Commission · European Union

Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.

BiotechMedtech+2
€7M – €8MSep'27
Innovate UK logo
Open

Innovate UK Themed Competitions

🇬🇧Innovate UK · United Kingdom

Funds sector-themed innovation competitions in the United Kingdom for hydrogen, manufacturing, agri-tech, health, and AI.

AgritechAI+13
£25K – £5M
Biotechnology and Biological Sciences Research Council logo
Open

BBSRC Applicant-Led (Responsive Mode) — Always Open

🇬🇧BBSRC · United Kingdom

Supports United Kingdom bioscience researchers through responsive grants that fund investigator-led foundational innovation.

BiotechAgritech+5
£2M
European Commission logo
Scheduled

Prevention and management of chronic non-communicable diseases in children and young people

🇪🇺European Commission · European Union

Funds implementation research that helps children and young people prevent and manage chronic disease equitably.

MedtechBiotech
€3M – €4MApr'27
European Commission logo
Scheduled

Innovative healthcare interventions for non-communicable diseases

🇪🇺European Commission · European Union

Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.

BiotechMedtech
€7M – €8MApr'27
European Commission logo
Scheduled

Portable and versatile Point-of-care diagnostics

🇪🇺European Commission · European Union

Funds €5–7M projects that make point-of-care diagnostics more portable, versatile, accurate and useful in clinical practice.

BiotechMedtech
€5M – €7MApr'27